Zhenhong Zhu
Publications by Year
Research Areas
Traditional Chinese Medicine Analysis, SARS-CoV-2 and COVID-19 Research, Natural product bioactivities and synthesis, Neurological Disease Mechanisms and Treatments, COVID-19 Clinical Research Studies
Most-Cited Works
- → Protective effect of N-acetylcysteine (NAC) on renal ischemia/reperfusion injury through Nrf2 signaling pathway(2014)65 cited
- → Synergistic protective effect of astragaloside IV–tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia(2011)57 cited
- → Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19(2024)34 cited
- Chuanxiongzine-astragaloside IV decreases IL-1β and Caspase-3 gene expressions in rat brain damaged by cerebral ischemia/reperfusion: a study of real-time quantitative PCR assay.(2011)
- → Pharmacokinetic and pharmacodynamic analysis of ferulic acid-puerarin-astragaloside in combination with neuroprotective in cerebral ischemia/reperfusion injury in rats(2015)10 cited
- → Molecular cloning and characterization of a cDNA encoding cycloartenol synthase from Fritillaria thunbergii Miq.(2012)9 cited
- [Protective effect of 3'-methoxy puerarin on cerebral ischemic injury/ reperfusion in rats].(2009)
- → Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19(2024)7 cited
- → Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity(2021)6 cited